IntelGenx Technologies Corp.
company.status.inactiveCIK 1098880fmd_13TC96WRG4P8C520ED20ZXQQMBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2024, 56 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2 | 5 | 5 | 5 | 2 | 1 | 2 | 2 | 1 | 1 |
| Cost of revenue | – | – | – | 0 | – | – | – | – | – | – |
| Gross profit | – | – | – | 5 | – | – | – | – | – | – |
| Research and development | 1 | 1 | 2 | 3 | 5 | 4 | 3 | 3 | 3 | 3 |
| Selling, general and administrative | 2 | 2 | 4 | 4 | 5 | 6 | 3 | 4 | 5 | 5 |
| Compensation and benefits | – | – | – | – | – | – | – | – | – | – |
| Total operating expenses | 3 | 4 | 6 | 8 | 11 | 10 | 8 | 10 | 10 | 11 |
| Operating income | (2) | 1 | (1) | (2) | (9) | (10) | (6) | (8) | (9) | (9) |
| Interest expense | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | (0) | (0) | (1) | (1) | (1) | (1) | (1) | (1) | (0) |
| Income before taxes | (2) | 1 | (1) | (3) | (10) | (11) | (7) | (9) | (11) | (10) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (2) | 1 | (1) | (3) | (10) | (11) | (7) | (9) | (11) | (10) |
| Net income | (2) | 1 | (1) | (3) | (10) | (11) | (7) | (9) | (11) | (10) |